Aptiv Solutions is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market.  The Company offers its clients an extensive portfolio of services including adaptive clinical trials, early phase product strategy, regulatory services, pharmacovigilance, clinical staffing and the operational support of a global clinical research organization. Aptiv has over 700 professionals in North America, Europe, the Middle East, Japan, and Australia, and operates out of 22 offices in 17 countries.

Investment Date

July 2008


In May 2014, Halifax successfully exited Aptiv Solutions through a sale to ICON plc, (NASDAQ: ICLR).